首页 | 本学科首页   官方微博 | 高级检索  
     


Prognostic significance of hepatocyte growth factor and c-MET expression in patients with diffuse large B-cell lymphoma
Authors:Kawano R  Ohshima K  Karube K  Yamaguchi T  Kohno S  Suzumiya J  Kikuchi M  Tamura K
Affiliation:Department of Pathology, School of Medicine, Fukuoka University, Fukuoka, Japan. rrriiikkkoookawa@yahoo.co.jp
Abstract:The expression and prognostic significance of hepatocyte growth factor (HGF) and its receptor c-MET (MET proto-oncogene) was analysed in 96 cases of diffuse large B-cell lymphoma (DLBCL). Tissue sections were immunohistochemically stained for HGF and c-Met. The prognosis of HGF-positive and c-Met-positive cases was significantly worse than negative cases (HGF: P = 0.0036; c-Met: P = 0.0002). In addition, in the low-risk international prognostic index group, HGF-negative and c-Met-negative cases had a significantly better prognosis than positive cases (HGF: P = 0.0009; c-Met: P < 0.0001). Our results suggest that HGF/c-MET is a useful clinical marker of prognosis for patients with DLBCL.
Keywords:diffuse large B-cell lymphoma    hepatocyte growth factor    c-MET    prognosis
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号